# H. Henry Li, MD – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/h-henry-li-md/48a3c6ac-6fb0-48b1-aeb8-7eaabe1322dc
Source feed: FDA_Inspections

> FDA inspection 1202279 of H. Henry Li, MD, March 24, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 50. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202279
- Company Name: H. Henry Li, MD
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 991215 - 2016-11-01

## Related Officers

- [Investigator](https://www.keypedia.com/people/david-l-chon/227b9c21-14c4-442b-bdc3-ad167567fd92)
- [Lucilla Facchin](https://www.keypedia.com/people/lucilla-facchin/e5c5c863-b2f4-44a8-8093-d1cb4f71949b)

Company: https://www.keypedia.com/companies/h-henry-li-md/b4081416-8113-468d-ba0f-ef800f30d2c5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
